(Q73213310)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Cardioprotection with a novel adenosine regulating agent mediated by intravascular adenosine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M A Kurz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

D A Bullough

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

C J Buggé

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

K M Mullane

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

M A Young

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

English

0 references

publication date

1 March 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Pharmacology

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

322

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

2-3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

211-220

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Functional role of intravascular coronary endothelial adenosine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Adenine nucleotide release from isolated perfused guinea pig hearts and extracellular formation of adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Adenosine-mediated inhibition of platelet aggregation by acadesine. A novel antithrombotic mechanism in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Adenosine: a physiological modulator of superoxide anion generation by human neutrophils.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Adenosine: an endogenous inhibitor of neutrophil-mediated injury to endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Effect of adenosine deaminase inhibitors on the heart's functional and biochemical recovery from ischemia: a study utilizing the isolated rat heart adapted to 31P nuclear magnetic resonance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Sustained protection by acadesine against ischemia- and reperfusion-induced injury. Studies in the transplanted rat heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Acadesine and myocardial protection. Studies of time of administration and dose-response relations in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Metabolic and functional effects of the nucleoside transport inhibitor R75231 in the ischaemic and blood reperfused rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Increased adenosine concentration in blood from ischemic myocardium by AICA riboside. Effects on flow, granulocytes, and injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Acadesine improves tolerance to ischemic injury in rat cardiac myocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Myocardial adenosine formation during hypoxia: Effects of ecto-5′-nucleotidase inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

AICA riboside improves myocardial ischemia in coronary microembolization in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Adenosine blockade during reperfusion reverses the infarct limiting effect in preconditioned canine hearts.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Nucleoside transport inhibitors enhance the infarct size-limiting effect of ischemic preconditioning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Cardiac contractile function following repetitive brief ischemia: effects of nucleoside transport inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Ischemic preconditioning increases adenosine release and 5'-nucleotidase activity during myocardial ischemia and reperfusion in dogs. Implications for myocardial salvage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Infarct size-limiting effect of ischemic preconditioning is blunted by inhibition of 5'-nucleotidase activity and attenuation of adenosine release

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Evidence that the adenosine A3 receptor may mediate the protection afforded by preconditioning in the isolated rabbit heart

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Protection against infarction afforded by preconditioning is mediated by A1 adenosine receptors in rabbit heart.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Harnessing an endogenous cardioprotective mechanism: cellular sources and sites of action of adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

The coronary endothelium: a highly active metabolic barrier for adenosine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Effect of intravenous adenosine on myocardial reperfusion injury in a model with low myocardial collateral blood flow.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Salutary effects of exogenous adenosine administration on in vivo myocardial stunning.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Reduction of the extent of ischemic myocardial injury by neutrophil depletion in the dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Effect of adenosine on myocardial 'stunning' in the dog.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Adenosine deaminase inhibition augments interstitial adenosine but does not attenuate myocardial infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Endothelial nucleotide catabolism and adenosine production.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Pretreatment with the adenosine A1 selective agonist, 2-chloro-N6-cyclopentyladenosine (CCPA), causes a sustained limitation of infarct size in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Acadesine extends the window of protection afforded by ischaemic preconditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Prevention of catecholamine-induced cardiac damage and death with a nucleoside transport inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Cardiac microdialysis to estimate interstitial adenosine and coronary blood flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

A comparison of adenosine-induced cardioprotection and ischemic preconditioning in dogs. Efficacy, time course, and role of KATP channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Progressive cardiac dysfunction with repeated pacing-induced ischemia: protection by AICA-riboside

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

A1 receptor mediated myocardial infarct size reduction by endogenous adenosine is exerted primarily during ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

Augmentation of endogenous adenosine attenuates myocardial 'stunning' independently of coronary flow or hemodynamic effects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2897%2900011-3

10.1016/S0014-2999(97)00011-3

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9098689%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference